GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Marketable Securities

Tci Gene (ROCO:6879) Marketable Securities : NT$203.6 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Tci Gene's Marketable Securities for the quarter that ended in Dec. 2023 was NT$203.6 Mil.

Tci Gene's annual Marketable Securities increased from Dec. 2021 (NT$4.0 Mil) to Dec. 2022 (NT$5.0 Mil) and increased from Dec. 2022 (NT$5.0 Mil) to Dec. 2023 (NT$203.6 Mil).


Tci Gene Marketable Securities Historical Data

The historical data trend for Tci Gene's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Marketable Securities Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
0.50 1.00 4.00 5.00 203.60

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Marketable Securities Get a 7-Day Free Trial Premium Member Only 4.00 3.50 5.00 153.60 203.60

Tci Gene Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Tci Gene  (ROCO:6879) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Tci Gene Marketable Securities Related Terms

Thank you for viewing the detailed overview of Tci Gene's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines